As the mRNA technology used in the current Pfizer, BioNTech, and Moderna emergency use ( EUA ) experimental “vaccines” makes its way into arms around the world, little has been reported about how the messenger RNA technology—whose purpose is to instruct the immune system to fight COVID-19 —was developed. For the product to get “safely into human cells, ” the mRNA needs to be encapsulated in fragments of fat called lipids. As Pfizer CEO Albert Bourla disclosed to Forbes :
“The whole mRNA platform is not how to build an mRNA molecule; that’s the easy thing. It is how to make sure the mRNA molecule will go into your cells and give the instructions.”
As reported by UncoverDC, developing vaccines against COVID-19 is a hugely profitable endeavor for pharmaceutical companies. In fact, for years to come, Pfizer, BioNTech, and Moderna are expected to receive billions of dollars from COVID-19 booster shots alone, in a market that is expected to be similar to the $6 billion in annual sales for flu vaccines. The same three companies are projected to sell $45 billion worth of vaccines in 2021.
Exactly how did Moderna and Pfizer develop the technology to get their mRNA drugs into human cells once their jab enters the body? The simple answer is—apparently, they didn’t. A months-long investigation by Forbes exposes “a complicated saga involving 15 years of legal battles and accusations of betrayal and deceit.” The probe explains:
“What is clear is that when humanity needed a way to deliver mRNA to human cells to arrest the pandemic, there was only one reliable method available—and it wasn’t one originated in-house by Pfizer, Moderna, BioNTech or any of the other major vaccine companies.”
According to Forbes, the scientist most responsible for the crucial mRNA delivery method for COVID vaccines is Ian MacLachlan—a 57-year-old biochemist from Canada. MacLachlan was the chief scientific officer of two small companies , Protiva Biotherapeutics and Tekmira Pharmaceuticals . Despite not currently being recognized or compensated by the giant pharmaceutical companies, while in this role, he commanded the team that developed the crucial technology now being […]
As the mRNA technology used in the current Pfizer, BioNTech, and Moderna emergency use ( EUA ) experimental “vaccines” makes its way into arms around the world, little has been reported about how the messenger RNA technology—whose purpose is to instruct the immune system to fight COVID-19 —was developed. For the product to get “safely into human cells, ” the mRNA needs to be encapsulated in fragments of fat called lipids. As Pfizer CEO Albert Bourla disclosed to Forbes :
“The whole mRNA platform is not how to build an mRNA molecule; that’s the easy thing. It is how to make sure the mRNA molecule will go into your cells and give the instructions.”
As reported by UncoverDC, developing vaccines against COVID-19 is a hugely profitable endeavor for pharmaceutical companies. In fact, for years to come, Pfizer, BioNTech, and Moderna are expected to receive billions of dollars from COVID-19 booster shots alone, in a market that is expected to be similar to the $6 billion in annual sales for flu vaccines. The same three companies are projected to sell $45 billion worth of vaccines in 2021.
Exactly how did Moderna and Pfizer develop the technology to get their mRNA drugs into human cells once their jab enters the body? The simple answer is—apparently, they didn’t. A months-long investigation by Forbes exposes “a complicated saga involving 15 years of legal battles and accusations of betrayal and deceit.” The probe explains:
“What is clear is that when humanity needed a way to deliver mRNA to human cells to arrest the pandemic, there was only one reliable method available—and it wasn’t one originated in-house by Pfizer, Moderna, BioNTech or any of the other major vaccine companies.”
According to Forbes, the scientist most responsible for the crucial mRNA delivery method for COVID vaccines is Ian MacLachlan—a 57-year-old biochemist from Canada. MacLachlan was the chief scientific officer of two small companies , Protiva Biotherapeutics and Tekmira Pharmaceuticals . Despite not currently being recognized or compensated by the giant pharmaceutical companies, while in this role, he commanded the team that developed the crucial technology now being […]
(post is archived)